Quarterly report pursuant to Section 13 or 15(d)


Cover - shares
9 Months Ended
Sep. 30, 2023
Nov. 07, 2023
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2023  
Document Transition Report false  
Entity File Number 001-37590  
Entity Registrant Name AVALO THERAPEUTICS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 45-0705648  
Entity Address, Address Line One 540 Gaither Road, Suite 400  
Entity Address, City or Town Rockville  
Entity Address, State or Province MD  
Entity Address, Postal Zip Code 20850  
City Area Code 410  
Local Phone Number 522-8707  
Title of 12(b) Security Common Stock, $0.001 par value  
Trading Symbol AVTX  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   192,382,419
Entity Central Index Key 0001534120  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Amendment Flag false